The $6.45 million will fund an expected 64 grants throughout 2020. One such project, winner of the ALA’s Innovation Award, is led by Gregg Duncan, PhD, from the University of Maryland in College Park. Dr. Duncan is developing a diagnostic tool that uses nanotechnology to monitor physical changes in mucus associated with obstructive lung diseases.
Among other innovative grant recipients are the two winners of the ALA’s Catalyst Award: Andrew Synn, MD, at Beth Israel Deaconess Medical Center in Boston is determining whether non-invasive imaging techniques can be used to detect pulmonary vascular disease, while Monica Cartelle-Gestal, PhD, from the University of Georgia Research Foundation in Athens, is studying a gene associated with whooping cough to develop a more effective vaccine against the condition.
Read more about ALA-funded, innovation-focused research projects here.
More articles on innovation:
Innovation platforms to be instrumental in hospital growth, Partners HealthCare’s Chris Coburn explains
Viewpoint: Rebranding as a tech company can spur innovation, consumerism for healthcare organizations
Best patient experience innovations at 17 health systems
